{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:41:52Z","timestamp":1793457712051,"version":"4.5.0"},"reference-count":187,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The Rh blood group system was last reviewed in\n                    <jats:italic>Immunohematology<\/jats:italic>\n                    in 2010 (Chou ST, Westhoff CM. The Rh and RhAG blood group systems. Immunohematology 2010;26:178\u201386). This update focuses on RHD, RhD structure, alterations in D expression, anti-D alloimmunization, and applications of RHD genotyping for weak and discrepant D phenotypes; identification of RHD genotypes that encode partial D phenotypes; and prevention and management of anti-D in pregnancy. Updates to the RHAG system and to RHCE and its encoded antigens are in recent or upcoming publications of\n                    <jats:italic>Immunohematology<\/jats:italic>\n                    , respectively.\n                  <\/jats:p>","DOI":"10.2478\/immunohematology-2025-007","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T14:54:48Z","timestamp":1755874488000},"page":"31-48","source":"Crossref","is-referenced-by-count":9,"title":["The Rh blood group system: RHD update"],"prefix":"10.2478","volume":"41","author":[{"given":"Glenn","family":"Ramsey","sequence":"first","affiliation":[{"name":"Department of Pathology, Feinberg School of Medicine , Northwestern University, and Blood Bank, Northwestern Memorial Hospital , Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"2026071214321550176_j_immunohematology-2025-007_ref_001","doi-asserted-by":"crossref","unstructured":"Chou ST, Westhoff CM. The Rh and RhAG blood group systems. Immunohematology 2010;26:178\u201386.","DOI":"10.21307\/immunohematology-2019-217"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_002","doi-asserted-by":"crossref","unstructured":"Flegel WA. Molecular genetics of RH and its clinical application. Transfus Clin Biol 2006;13:4\u201312.","DOI":"10.1016\/j.tracli.2006.02.011"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_003","doi-asserted-by":"crossref","unstructured":"Li X, Jayachandran S, Nguyen HH, Chan MK. Structure of the Nitrosomonas europaea Rh protein. Proc Nat Acad Sci U S A 2007;104:19279\u201384.","DOI":"10.1073\/pnas.0709710104"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_004","doi-asserted-by":"crossref","unstructured":"Lupo D, Li X, Durand A, et al. The 1.3-\u00c5 resolution structure of Nitrosomonas europaea Rh50 and mechanistic implications for NH3 transport by Rhesus family proteins. Proc Nat Acad Sci U S A 2007;104:19303\u20138.","DOI":"10.1073\/pnas.0706563104"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_005","doi-asserted-by":"crossref","unstructured":"Gruswitz F, Chaudhury S, Ho JD, et al. Function of human Rh based on structure of RhCG at 2.1 \u00c5. Proc Nat Acad Sci U S A 2010;9638\u201343.","DOI":"10.1073\/pnas.1003587107"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_006","doi-asserted-by":"crossref","unstructured":"Silvy M, Chapel-Hernandes S, Callebaut I, et al. Characterization of novel RHD alleles: relationship between phenotype, genotype, and trimeric architecture. Transfusion 2012;52:2020\u20139.","DOI":"10.1111\/j.1537-2995.2011.03544.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_007","doi-asserted-by":"crossref","unstructured":"De Brevern AG, Floch A, Barrault A, et al. Alloimmunization risk associated with amino acid 223 substitution in the RhD protein: analysis in the light of molecular modeling. Transfusion 2018;58:2683\u201392.","DOI":"10.1111\/trf.14809"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_008","doi-asserted-by":"crossref","unstructured":"Vallese F, Kim K, Yen LY, et al. Architecture of the human erythrocyte ankyrin-1 complex. Nat Struct Mol Biol 2022; 29:706\u201318.","DOI":"10.1038\/s41594-022-00792-w"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_009","doi-asserted-by":"crossref","unstructured":"Floch A, Galochkina T, Pirenne F, Tournamille C, de Brevern AG. Molecular dynamics of the human RhD and RhAG blood group proteins. Front Chem 2024;12:1360392.","DOI":"10.3389\/fchem.2024.1360392"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_010","doi-asserted-by":"crossref","unstructured":"Floch A, Pirenne F, Barrault A, et al. Insights into anti-D formation in carriers of RhD variants through studies of 3D intraprotein interactions. Transfusion 2021;61:1286\u2013301.","DOI":"10.1111\/trf.16301"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_011","doi-asserted-by":"crossref","unstructured":"Trueba-G\u00f3mez R, Rosenfeld-Mann F, Baptista-Gonz\u00e1lez HA, Dom\u00ednguez-L\u00f3pez ML, Estrada-Ju\u00e1rez H. Use of computational biology to compare the theoretical tertiary structures of the most common forms of RhCE and RhD. Vox Sang 2023;118:881\u201390.","DOI":"10.1111\/vox.13509"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_012","doi-asserted-by":"crossref","unstructured":"Nicolas V, Mouro-Chanteloup I, Lopez C, et al. Functional interaction between Rh proteins and the spectrin-based skeleton in erythroid and epithelial cells. Transfus Clin Biol 2006;13:23\u20138.","DOI":"10.1016\/j.tracli.2006.02.019"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_013","doi-asserted-by":"crossref","unstructured":"Blanc M, David F, Abrami L, et al. SwissPalm: protein palmitoylation database. F1000Res 2015;4:261. Release 5, 2025. Available from https:\/\/swisspalm.org. Accessed 27 May 2025.","DOI":"10.12688\/f1000research.6464.1"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_014","doi-asserted-by":"crossref","unstructured":"Daniels G. Human blood groups. 3rd ed. Oxford: Wiley-Blackwell, 2013:182\u2013258.","DOI":"10.1002\/9781118493595"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_015","doi-asserted-by":"crossref","unstructured":"Daniels G. Variants of RhD\u2014current testing and clinical consequences. Br J Haematol 2013;161:461\u201370.","DOI":"10.1111\/bjh.12275"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_016","doi-asserted-by":"crossref","unstructured":"Mazi\u00e8res S, Condemi S, El Nemer W, Chiaroni J. Rapid change in red cell blood group systems after the main Out of Africa of Homo sapiens. Sci Rep 2025;15:1597.","DOI":"10.1038\/s41598-024-83023-0"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_017","doi-asserted-by":"crossref","unstructured":"Blancher A, Socha WW. The Rhesus system. In: Blancher A, Klein J, Socha WW, Eds. Molecular biology and evolution of blood group and MHC antigens in primates. Berlin: Springer-Verlag, 1997:147-218.","DOI":"10.1007\/978-3-642-59086-3_6"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_018","doi-asserted-by":"crossref","unstructured":"Anstee DJ. The relationship between blood groups and disease. Blood 2010;115:4635\u201343.","DOI":"10.1182\/blood-2010-01-261859"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_019","doi-asserted-by":"crossref","unstructured":"Flegr J, Toman J, H\u016fla M, Ka\u0148kov\u00e1 S. The role of balancing selection in maintaining human RhD blood group polymorphism: a preregistered cross-sectional study. J Evol Biol 2021;34:426\u201338.","DOI":"10.1111\/jeb.13745"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_020","doi-asserted-by":"crossref","unstructured":"Bruun-Rasmussen P, Dziegiel MH, Banasik K, Johansson PI, Brunak S. Associations of ABO and Rhesus D blood groups with phenome-wide disease incidence: a 41-year retrospective cohort study of 482,914 patients. eLife 2023;12:e83116.","DOI":"10.7554\/eLife.83116"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_021","unstructured":"International Society of Blood Transfusion. RHD blood group alleles. v6.4. Red cell immunogenetics and blood group terminology. Amsterdam: International Society of Blood Transfusion, 2023. Available from https:\/\/www.isbtweb.org\/resource\/004rhd.html. Accessed 26 May 2025."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_022","doi-asserted-by":"crossref","unstructured":"Wagner FF, Flegel WA. The Rhesus site. Transfus Med Hemother 2014;41:357-63. Human RhesusBase version 2.5.2. 18 March 2020. Available from https:\/\/www.rhesusbase.info\/. Accessed 26 May 2025.","DOI":"10.1159\/000366176"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_023","doi-asserted-by":"crossref","unstructured":"Floch A, T\u00e9letch\u00e9a S, Tournamille C, de Brevern AG, Pirenne F. A review of the literature organized into a new database: RHeference. Transfus Med Rev 2021;35:70\u20137. Available from https:\/\/www.rheference.org. Accessed 26 May 2025.","DOI":"10.1016\/j.tmrv.2021.04.002"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_024","doi-asserted-by":"crossref","unstructured":"Tippett P, Lomas-Francis C, Wallace M. The Rh antigen D: partial D antigens and associated low incidence antigens. Vox Sang 1996;70:123\u201331.","DOI":"10.1111\/j.1423-0410.1996.tb01309.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_025","doi-asserted-by":"crossref","unstructured":"Sandler SG, Flegel WA, Westhoff CM, et al. It\u2019s time to phase in RHD genotyping for patients with a serologic weak D phenotype. Transfusion 2015;55:680\u20139.","DOI":"10.1111\/trf.12941"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_026","doi-asserted-by":"crossref","unstructured":"Flegel WA, Denomme GA, Queenan JT, et al. It\u2019s time to phase out \u201cserologic weak D phenotype\u201d and resolve D types with RHD genotyping including weak D type 4. Transfusion 2020;60:855\u20139.","DOI":"10.1111\/trf.15741"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_027","doi-asserted-by":"crossref","unstructured":"Ramsey G, Park YA, Eder AF, et al. Obstetric and newborn weak D-phenotype RBC testing and Rh immune globulin management recommendations: lessons from a blinded specimen-testing survey of 81 transfusion services. Arch Pathol Lab Med 2023;147:71-8.","DOI":"10.5858\/arpa.2021-0250-CP"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_028","doi-asserted-by":"crossref","unstructured":"Theiler C, Lomas-Francis C, Vege S, et al. Weak and partial D phenotyping: a comparison study between molecular and serologic results. Immunohematology 2024;40:159\u201365.","DOI":"10.2478\/immunohematology-2024-022"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_029","doi-asserted-by":"crossref","unstructured":"Denomme G, Dake LLR, Vilensky D, Ramyar L, Judd WJ. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques. Transfusion 2008; 48:473\u20138.","DOI":"10.1111\/j.1537-2995.2007.01551.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_030","doi-asserted-by":"crossref","unstructured":"Avent ND. New insight into the Rh system: structure and function. ISBT Sci Ser 2007;2:35\u201345.","DOI":"10.1111\/j.1751-2824.2007.00055.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_031","doi-asserted-by":"crossref","unstructured":"Fennell K, Hoffman R, Yoshida K, et al. Effect on gene expression of three allelic variants in GATA motifs of ABO, RHD, and RHCE regulatory elements. Transfusion 2017;57:2804\u20138.","DOI":"10.1111\/trf.14299"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_032","doi-asserted-by":"crossref","unstructured":"McGowan EC, Wu PC, Hellberg \u00c5, Lopez GH, Hyland CA, Olsson ML. A bioinformatically initiated approach to evaluate GATA1 regulatory regions in samples with weak D, Del, or D-phenotypes despite normal RHD exons. Transfus Med Hemother 2024;51:252\u201364.","DOI":"10.1159\/000538469"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_033","doi-asserted-by":"crossref","unstructured":"Li Q, Hou L, Guo Z, Ye L, Yue D, Zhu Z. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai. Vox Sang 2009;97:139\u201346.","DOI":"10.1111\/j.1423-0410.2009.01181.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_034","doi-asserted-by":"crossref","unstructured":"Christiansen M, S\u00f8rensen BS, Grunnet N. RHD positive among C\/E+ and D- blood donors in Denmark. Transfusion 2010;50:1460\u20134.","DOI":"10.1111\/j.1537-2995.2010.02611.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_035","doi-asserted-by":"crossref","unstructured":"Wagner FF, Gassner C, M\u00fcller TH, Sch\u00f6nitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999;93:385\u201393.","DOI":"10.1182\/blood.V93.1.385"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_036","doi-asserted-by":"crossref","unstructured":"Flegel WA, von Zabern I, Wagner FF. Six years\u2019 experience performing RHD genotyping to confirm D\u2013 red blood cell units in Germany for preventing anti-D immunizations. Transfusion 2009;49:465-71.","DOI":"10.1111\/j.1537-2995.2008.01975.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_037","doi-asserted-by":"crossref","unstructured":"Trueba-G\u00f3mez R, Rosenfeld-Mann F, Estrada-Ju\u00e1rez H. Prediction of the antigenic regions in eight RhD variants identified by computational biology. Vox Sang 2024;119:590\u20137.","DOI":"10.1111\/vox.13620"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_038","doi-asserted-by":"crossref","unstructured":"Lejon Crottet S, Haer-Wigman L, Gowland P, Fontana S, Niederhauser C, Hustinx H. Serologic and molecular investigations of DARI (weak D type 4.2), DARI.2, DAR1.3, DAR2 (DARE), and DARA. Transfusion 2013;53:3000\u20138.","DOI":"10.1111\/trf.12363"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_039","doi-asserted-by":"crossref","unstructured":"Srivastasa K, Polin H, Sheldon SL, et al. The DAU cluster: a comparative analysis of 18 RHD alleles, some forming partial D antigens. Transfusion 2016;56:2520\u201331.","DOI":"10.1111\/trf.13739"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_040","doi-asserted-by":"crossref","unstructured":"Roussel M, Poupel S, Nataf J, et al. RHD*DOLl and RHD*DOL2 encode a partial D antigen and are in cis with the rare RHCE*ceBI allele in people of African descent. Transfusion 2013;53:363\u201372.","DOI":"10.1111\/j.1537-2995.2012.03743.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_041","doi-asserted-by":"crossref","unstructured":"Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001;2:10.","DOI":"10.1186\/1471-2156-2-10"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_042","doi-asserted-by":"crossref","unstructured":"Fichou Y, Gehannin P, Corre M, et al. Extensive functional analyses of RHD splice site variants: insights into the potential role of splicing in the physiology of Rh. Transfusion 2015;55:1432\u201343.","DOI":"10.1111\/trf.13083"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_043","doi-asserted-by":"crossref","unstructured":"Ogasawara K, Sasaki K, Isa K, et al. Weak D alleles in Japanese: a c.960G>A silent mutation in exon 7 of the RHD gene that affects D expression. Vox Sang 2016;110:179\u201384.","DOI":"10.1111\/vox.12322"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_044","doi-asserted-by":"crossref","unstructured":"Raud L, Le Tertre M, Vigneron L, et al. Missense RHD single nucleotide variants induce weakened D antigen expression by altering splicing and\/or protein expression. Transfusion 2021;61:2468\u201376.","DOI":"10.1111\/trf.16538"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_045","doi-asserted-by":"crossref","unstructured":"Floch A, Vege S, Berardi P, et al. An intron c.149-2632T>A change in RHD is associated with aberrant transcription and very weak D phenotype. Transfusion 2022;62:E14\u20136.","DOI":"10.1111\/trf.16774"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_046","doi-asserted-by":"crossref","unstructured":"Fichou Y. Hybrids and microconversions in RH genes: investigation and implication in transfusion therapy. Ann Blood 2023;8:7.","DOI":"10.21037\/aob-21-55"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_047","doi-asserted-by":"crossref","unstructured":"Flegel WA, Eicher NI, Doescher A, et al. In-frame triplet deletions in RHD alter the D antigen phenotype. Transfusion 2006;46:2156\u201361.","DOI":"10.1111\/j.1537-2995.2006.01046.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_048","doi-asserted-by":"crossref","unstructured":"Flegel WA, Srivastava K. Frameshift variations in the RHD coding sequence: molecular mechanisms permitting protein expression. Transfusion 2020;60:2737\u201344.","DOI":"10.1111\/trf.16123"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_049","doi-asserted-by":"crossref","unstructured":"Wagner FF. Serology and molecular biology of DEL: a narrative review. Ann Blood 2023;8:28.","DOI":"10.21037\/aob-22-16"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_050","doi-asserted-by":"crossref","unstructured":"Fichou Y, Parchure D, Gogri H, et al. Molecular basis of weak D expression in the Indian population and report of a novel, predominant variant RHD allele. Transfusion 2018;58: 1540\u20139.","DOI":"10.1111\/trf.14552"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_051","doi-asserted-by":"crossref","unstructured":"Richard M, Perrault J, Constanzo-Yanez J, Khalif\u00e9 S, St-Louis M. A new DEL variant caused by exon 8 deletion. Transfusion 2007;47:852\u20137.","DOI":"10.1111\/j.1537-2995.2007.01199.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_052","doi-asserted-by":"crossref","unstructured":"Srivastava K, Stiles DA, Wagner FF, Flegel WA. Two large deletions extending beyond either end of the RHD gene and their red cell phenotypes. J Hum Genet 2018;63:27\u201335.","DOI":"10.1038\/s10038-017-0345-3"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_053","unstructured":"Tsunemaya H, Isa K, Ogasawara K, et al. Identification of a mutation in the RHAG gene of Japanese with weak D phenotype. Transfusion 2013;53(Suppl 2):167A."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_054","doi-asserted-by":"crossref","unstructured":"Wen J, Verhagen OJHM, Jia S, et al. A variant RhAG protein encoded by the RHAG*572A allele causes serological weak D expression while maintaining normal RhCE phenotypes. Transfusion 2019;59:405\u201311.","DOI":"10.1111\/trf.14969"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_055","doi-asserted-by":"crossref","unstructured":"Satchwell TJ, Bell AJ, Hawley BR, et al. Severe ankyrin-R deficiency results in impaired surface retention and lysosomal degradation of RhAG in human erythroblasts. Haematologica 2016;101:1018\u201327.","DOI":"10.3324\/haematol.2016.146209"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_056","doi-asserted-by":"crossref","unstructured":"Shao CP, Maas JH, Su YQ, K\u00f6hler M, Legler TJ. Molecular background of Rh D-positive, D-negative, Del and weak D phenotypes in Chinese. Vox Sang 2002;83:156-61.","DOI":"10.1046\/j.1423-0410.2002.00192.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_057","doi-asserted-by":"crossref","unstructured":"Tilley L. An update on the RHAG blood group system. Immunohematology 2025;41:1\u20133. DOI: 10.2478\/immunohematology-2025-002.","DOI":"10.2478\/immunohematology-2025-002"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_058","unstructured":"Vege S, Floch A. An update on the Rh blood group system: RHCE. Immunohematology (in press)."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_059","doi-asserted-by":"crossref","unstructured":"Denomme GA, Wang D, Matheson KA, Titolo D. The proximal cis-regulatory region of the RHD\/RHCE promoter is 105 bp and contains a 55-bp core devoid of known binding motifs but necessary for transcription. Transfusion 2009;49:1361\u20139.","DOI":"10.1111\/j.1537-2995.2009.02162.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_060","doi-asserted-by":"crossref","unstructured":"Pham BN, Roussel M, Peyrard T, et al. Anti-D investigations in individuals expressing weak D type 1 or weak D type 2: alio- or autoantibodies? Transfusion 2011;51:2679\u201385.","DOI":"10.1111\/j.1537-2995.2011.03207.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_061","doi-asserted-by":"crossref","unstructured":"Morin P, Perrault J, St-Louis M, Leiva-Torres GA, Robitaille N, Tr\u00e9panier P. Weak D type 42: antigen density and risk of alloimmunization in the province of Qu\u00e9bec. Vox Sang 2022;117:943\u20138.","DOI":"10.1111\/vox.13271"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_062","doi-asserted-by":"crossref","unstructured":"Raud L, Ka C, Gourlaouen I, et al. Functional analysis of novel RHD variants: splicing disruption is likely to be a common mechanism of variant D phenotype. Transfusion 2019;59:1367\u201375.","DOI":"10.1111\/trf.15210"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_063","doi-asserted-by":"crossref","unstructured":"Matzhold EM, Polin H, K\u00f6rm\u00f6czi G, et al. RHD del28Phe (DMW) encoded by a novel in-frame deletion resulting in reduced D antigen expression. Transfusion 2019;59:3033\u20134.","DOI":"10.1111\/trf.15459"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_064","doi-asserted-by":"crossref","unstructured":"Pereira J, Rodrigues M J, Tilley L, et al. RhD variant caused by an in-frame triplet duplication in the RHD gene. Transfusion 2011;51:570\u20133.","DOI":"10.1111\/j.1537-2995.2010.02856.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_065","unstructured":"Tilley L, Rodrigues MJ, Malde R, et al. Two novel RhD variants caused by triplet deletions in the RhD gene. Transfusion Med 2007;17(Suppl 1):31."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_066","doi-asserted-by":"crossref","unstructured":"Gassner C, Doescher A, Drnovsek TD, et al. Presence of RHD in serologically D-, C\/E+ individuals: a European multicenter study. Transfusion 2005;45:527\u201338.","DOI":"10.1111\/j.0041-1132.2004.04211.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_067","unstructured":"Nogues N, Tarrago M, Subirana L, et al. RHD null alleles in the Spanish population. Vox Sang 2007;93(Suppl 1):205."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_068","doi-asserted-by":"crossref","unstructured":"Lopez GH, Turner RM, McGowan EC, et al. A DEL phenotype attributed to RHD exon 9 sequence deletion: slipped-strand mispairing and blood group polymorphisms. Transfusion 2018;58:685\u201391.","DOI":"10.1111\/trf.14439"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_069","doi-asserted-by":"crossref","unstructured":"Fichou Y, Chen J, Le Mar\u00e9chal C, et al. Weak D caused by a founder deletion in the RHD gene. Transfusion 2012;52: 2348\u201355.","DOI":"10.1111\/j.1537-2995.2012.03606.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_070","unstructured":"International Society of Blood Transfusion. RHAG blood group alleles. v6.4. Red cell immunogenetics and blood group terminology. 2023. Available from https:\/\/www.isbtweb.org\/resource\/030rhag.html. Accessed 26 May 2025."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_071","doi-asserted-by":"crossref","unstructured":"Hartel-Schenk S, Agre P. Mammalian red cell membrane Rh polypeptides are selectively palmitoylated subunits of a macromolecular complex. J Biol Chem 1992;267:5569\u201374.","DOI":"10.1016\/S0021-9258(18)42803-7"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_072","doi-asserted-by":"crossref","unstructured":"Blaskovic S, Blanc M, Gisou van der Goot F. What does S-palmitoylation do to membrane proteins? FEBS J 2013; 280:2766\u201374.","DOI":"10.1111\/febs.12263"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_073","doi-asserted-by":"crossref","unstructured":"Mesquita FS, Abrami L, Linder ME, Bamji SX, Dickinson BC, Gisou van der Goot F. Mechanisms and functions of protein S-acylation. Nat Rev Molec Cell Biol 2024;25:488\u2013509.","DOI":"10.1038\/s41580-024-00700-8"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_074","doi-asserted-by":"crossref","unstructured":"\u0141ach A, Gryzbek M, Heger E, et al. Palmitoylation of MPP1 (membrane-palmitoylated proteinl)\/p55 is crucial for lateral membrane organization in erythroid cells. J Biol Chem 2012;287:18974\u201384.","DOI":"10.1074\/jbc.M111.332981"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_075","doi-asserted-by":"crossref","unstructured":"\u0141ach A, Gryzbek M, Heger E, et al. Withdrawal: palmitoylation of MPP1 (membrane-palmitoylated proteinl)\/p55 is crucial for lateral membrane organization in erythroid cells. J Biol Chem 2018;293:2786.","DOI":"10.1074\/jbc.W118.002209"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_076","doi-asserted-by":"crossref","unstructured":"Yazer MH, Triulzi DJ, Sperry JL, Seheult JN. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products. Transfusion 2021;61(Suppl l):S150\u20138.","DOI":"10.1111\/trf.16495"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_077","doi-asserted-by":"crossref","unstructured":"Seheult JN, Callum J, Delaney M, et al. Rate of D- alloimmunization in trauma does not depend on the number of RhD-positive units transfused: the BEST collaborative study. Transfusion 2022;62(Suppl l):S185\u201392.","DOI":"10.1111\/trf.16952"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_078","doi-asserted-by":"crossref","unstructured":"Ji Y, Luo G, Fu Y. Incidence of anti-D alloimmunization in D-negative individuals receiving D-positive red blood cell transfusion: a systematic review and meta-analysis. Vox Sang 2022;117:633\u201340.","DOI":"10.1111\/vox.13232"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_079","doi-asserted-by":"crossref","unstructured":"Hubert T, Kerkhoffs JL, Brand A, Schonewille H. Anti-D immunization after D positive platelet transfusions in D negative recipients: a systematic review and meta-analysis. Transfusion 2024;64:933\u201345.","DOI":"10.1111\/trf.17833"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_080","doi-asserted-by":"crossref","unstructured":"Perez-Alvarez I, Hayes C, Hailemariam T, Shin E, Hutchinson T, Klapper E. RHD genotyping of serologic RhD-negative blood donors in a hospital-based blood donor center. Transfusion 2019;59:2422\u20138.","DOI":"10.1111\/trf.15325"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_081","unstructured":"Pardi C, Hellberg \u00c5, Isakson P. Single-exon fetal RHD genotyping: a 31-month follow up in the obstetric population of Western Sweden. Blood Transfus 2024;22:387\u201394."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_082","doi-asserted-by":"crossref","unstructured":"Krog GR, Clausen FB, Berkowicz A, et al. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients? Transfusion 2011;51:2278\u201385.","DOI":"10.1111\/j.1537-2995.2011.03156.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_083","doi-asserted-by":"crossref","unstructured":"Stegmann TC, Veldhuisen B, Bijman R, et al. Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women. Br J Haematol 2016;173:469\u201379.","DOI":"10.1111\/bjh.13960"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_084","doi-asserted-by":"crossref","unstructured":"Crottet SL, Henny C, Meyer S, et al. Six years\u2019 experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfus Apher Sci 2014;50:169\u201374.","DOI":"10.1016\/j.transci.2014.02.011"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_085","doi-asserted-by":"crossref","unstructured":"Polin H, Danzer M, Gaszner W, et al. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria. Transfusion 2009;49:676-81.","DOI":"10.1111\/j.1537-2995.2008.02046.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_086","doi-asserted-by":"crossref","unstructured":"Orzi\u0144ska A, Guz K, Polin H, et al. RHD variants in Polish blood donors routinely typed as D negative. Transfusion 2013;53(Suppl 2):2945-53.","DOI":"10.1111\/trf.12230"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_087","doi-asserted-by":"crossref","unstructured":"Vendrame TAP, Arnoni CP, Muniz JG, et al. Characterization of RHD alleles present in serologically R HD-negative donors determined by a sensitive microplate technique. Vox Sang 2019;114:869\u201375.","DOI":"10.1111\/vox.12851"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_088","doi-asserted-by":"crossref","unstructured":"Trucco Boggione C, Luj\u00e1n Brajovich ME, Tarrag\u00f3 M, et al. Molecular structures identified in serologically D- samples of an admixed population. Transfusion 2014;54:2456\u201362.","DOI":"10.1111\/trf.12691"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_089","unstructured":"Ye S, Wu D, Wang M, et al. A comprehensive investigation of RHD polymorphisms in the Chinese Han population in Xi'an. Blood Transfus 2014;12:396\u2013404."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_090","doi-asserted-by":"crossref","unstructured":"Thongbut J, Laengsri V, Raud L, et al. Nation-wide investigation of RHD variants in Thai blood donors: impact for molecular diagnostics. Transfusion 2021;61:931\u20138.","DOI":"10.1111\/trf.16242"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_091","doi-asserted-by":"crossref","unstructured":"Kim JY, Kim SY, Kim C, Yon GS, Park SS. Molecular characterization of D- Korean persons: development of a diagnostic strategy. Transfusion 2005;45:345\u201352.","DOI":"10.1111\/j.1537-2995.2005.04311.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_092","doi-asserted-by":"crossref","unstructured":"Ogasawara K, Suzuki Y, Sasaki K, et al. Molecular basis for D- Japanese: identification of novel DEL and D- alleles. Vox Sang 2015;109:359\u201365.","DOI":"10.1111\/vox.12290"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_093","doi-asserted-by":"crossref","unstructured":"Flegel WA, Srivastava K. 40 Years of researching the Del phenotype results in a change of transfusion practice. Transfusion 2024;64:1187\u201390.","DOI":"10.1111\/trf.17913"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_094","doi-asserted-by":"crossref","unstructured":"Hess JR. Safe transfusion in Asian-type DEL. Blood 2023:141:2044\u20136.","DOI":"10.1182\/blood.2023019646"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_095","doi-asserted-by":"crossref","unstructured":"Bowman J. Thirty-five years of Rh prophylaxis. Transfusion 2003;43:1661\u20136.","DOI":"10.1111\/j.0041-1132.2003.00632.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_096","doi-asserted-by":"crossref","unstructured":"Pegoraro V, Urbinati D, Visser GHA, et al. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children. PLoS ONE 2020;15:e0235807.","DOI":"10.1371\/journal.pone.0235807"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_097","unstructured":"Luo X, Keller M A, James I, et al. Strategies to identify candidates for D variant genotyping. Blood Transfus 2018;16:293\u2013301."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_098","doi-asserted-by":"crossref","unstructured":"Horn TN, Keller J, Keller MA, Klinger L. Identifying obstetrics patients in whom RHD genotyping can be used to assess risk of D alloimmunization. Immunohematology 2020;36:146\u201351.","DOI":"10.21307\/immunohematology-2020-054"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_099","doi-asserted-by":"crossref","unstructured":"Arnoni CA, Vendrame TA, Silva FS, et al. Serologic profiling of D variants in donor routine: unveiling the impact on false-negative results and alloimmunization. Immunohematology 2024;40:47\u201353.","DOI":"10.2478\/immunohematology-2024-007"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_100","doi-asserted-by":"crossref","unstructured":"Ramsey G, Barriteau CM. Estimating the serological under-recognition of patients with weak or partial RHD variants. Transfusion 2024;64:920\u20138.","DOI":"10.1111\/trf.17810"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_101","doi-asserted-by":"crossref","unstructured":"Barriteau CM, Lindholm PL, Hartman K, Sumugod RD, Ramsey G. RHD genotyping to resolve weak and discrepant RhD patient phenotypes. Transfusion 2022;62:2194\u20139.","DOI":"10.1111\/trf.17145"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_102","doi-asserted-by":"crossref","unstructured":"Londero D, Monge J, Hellberg A. A multi-centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice. Vox Sang 2020;115:241\u20138.","DOI":"10.1111\/vox.12886"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_103","doi-asserted-by":"crossref","unstructured":"Westhoff CM, Floch A. Blood group genotype matching for transfusion. Br J Haematol 2025;206:18\u201332.","DOI":"10.1111\/bjh.19664"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_104","doi-asserted-by":"crossref","unstructured":"Vege S, Sprog\u00f8e U, Lomas-Francis C, et al. Impact of RHD genotyping on transfusion practice in Denmark and the United States and identification of novel RHD alleles. Transfusion 2021;61:256\u201365.","DOI":"10.1111\/trf.16100"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_105","doi-asserted-by":"crossref","unstructured":"Madgett TE, Tounsi WA, Halawani AJ, Avent ND. RHD molecular analysis: from discovery to next generation sequencing. Ann Blood 2023;8:36.","DOI":"10.21037\/aob-22-41"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_106","doi-asserted-by":"crossref","unstructured":"Khandelwal A, Zittermann S, Sierocinski T, Montemayor C. RH genotyping by next-generation sequencing. Ann Blood 2023;8:39.","DOI":"10.21037\/aob-23-10"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_107","unstructured":"Lane WJ, Westhoff CM, Gleadall NS, et al. Automated typing of red blood cell and platelet antigens; a whole-genome sequencing study. Lancet Haematol 2018;5:e241\u201351."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_108","doi-asserted-by":"crossref","unstructured":"Halls JBL, Vege S, Simmons DP, et al. Overcoming the challenges of interpreting complex and uncommon RH alleles from whole genomes. Vox Sang 2020;115:790\u2013801.","DOI":"10.1111\/vox.12963"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_109","doi-asserted-by":"crossref","unstructured":"Chen S, Francioli LC, Goodrich JK, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 2024;625:92\u2013100.","DOI":"10.1038\/s41586-023-06045-0"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_110","unstructured":"The All of Us Research Program Genomics Investigators. Genomic data in the All of Us research program. Nature 2024;627:340\u20136."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_111","doi-asserted-by":"crossref","unstructured":"Fung-Kee-Fung K, Wong K, Walsh J, Hamel C, Clarke G. Guideline no. 448: prevention of Rh D alloimmunization. J Obstet Gynaecol Can 2024;46:102449.","DOI":"10.1016\/j.jogc.2024.102449"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_112","unstructured":"Westhoff CM, Nance S, Lomas-Francis C, Keller M, Chou ST. Experience with RHD*weak D type 4.0 in the USA. Blood Transfus 2019;17:91\u20133."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_113","doi-asserted-by":"crossref","unstructured":"Miranda MR, Delfino dos Santos T, Castilho L. Systematic RHD genotyping in Brazilians reveals a high frequency of partial D in transfused patients serologically typed as weak D. Transfus Apher Sci 2021;60:103235.","DOI":"10.1016\/j.transci.2021.103235"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_114","doi-asserted-by":"crossref","unstructured":"Jenkins CM, Johnson ST, Bellissimo DB, Gottschall JL. Incidence of weak D in blood donors typed as D positive by the Olympus PK 7200. Immunohematology 2005;21:152\u20134.","DOI":"10.21307\/immunohematology-2019-411"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_115","doi-asserted-by":"crossref","unstructured":"Haspel RL, Westhoff CM. How do I manage Rh typing in obstetric patients? Transfusion 2015;55:470\u20134.","DOI":"10.1111\/trf.12995"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_116","unstructured":"Mamone L, James IL, Yoon EJ, Alsammak M. Clinical and cost efficacy of molecular RhD genotyping. Transfusion 2018;58(Suppl 2):178A."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_117","doi-asserted-by":"crossref","unstructured":"Uzuni A, Wlosinski L, Lopez-Plaza I. Updated evaluation of RhD status among women of child-bearing age in Detroit, Michigan. Am J Clin Pathol 2021;156:1000\u20136.","DOI":"10.1093\/ajcp\/aqab061"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_118","doi-asserted-by":"crossref","unstructured":"Hudgins JP, Matsushita C, Tuma CW, O\u2019Brien L, Shulman IA. Identification of RHD allelic variants discovered by atypical typing results on the NEO\/Echo platforms. Immunohematology 2021;37:165\u201370.","DOI":"10.21307\/immunohematology-2021-027"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_119","doi-asserted-by":"crossref","unstructured":"Keller MA. RH genetic variation and the impact for typing and personalized transfusion strategies: a narrative review. Ann Blood 2023;8:18.","DOI":"10.21037\/aob-22-6"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_120","doi-asserted-by":"crossref","unstructured":"Denomme GA, Wagner FF, Fernandes BJ, Li W, Flegel WA. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion 2005;45:1554\u201360.","DOI":"10.1111\/j.1537-2995.2005.00586.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_121","doi-asserted-by":"crossref","unstructured":"Clarke G, Hannon J, Berardi P, et al. Resolving variable maternal D typing using serology and genotyping in selected prenatal patients. Transfusion 2016;56:2980\u20135.","DOI":"10.1111\/trf.13798"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_122","doi-asserted-by":"crossref","unstructured":"Leiva-Torres GA, Chevrier M, Constanzo-Yanez J, et al. High prevalence of weak D type 42 in a large-scale RHD genotyping program in the province of Quebec (Canada). Transfusion 2021;61:2727\u201335.","DOI":"10.1111\/trf.16518"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_123","doi-asserted-by":"crossref","unstructured":"Polin H, Danzer M, Hofer K, Gassner W, Gabriel C. Effective molecular RHD typing strategy for blood donations. Transfusion 2007;47:1350\u20135.","DOI":"10.1111\/j.1537-2995.2007.01278.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_124","doi-asserted-by":"crossref","unstructured":"Juhl D, Luckner K, Brockmann C, et al. RHD-negative red cells may be avoided for patients with ambiguous serologic typing for the RHD antigen. Transfusion 2024;64:281\u20138.","DOI":"10.1111\/trf.17691"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_125","doi-asserted-by":"crossref","unstructured":"M\u00fcller TH, Wagner FF, Trockenbacher A, et al. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion 2001;41: 45\u201352.","DOI":"10.1046\/j.1537-2995.2001.41010045.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_126","doi-asserted-by":"crossref","unstructured":"Fichou Y, Le Mar\u00e9chal C, Jamet D, et al. Establishment of a medium-throughput approach for the genotyping of RHD variants and report of nine novel rare alleles. Transfusion 2013;53:1821\u20138.","DOI":"10.1111\/trf.12009"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_127","doi-asserted-by":"crossref","unstructured":"Van Sandt VST, Gassner C, Emonds M, Legler TJ, Mahieu S, K\u00f6rm\u00f6czi GF. RHD variants in Flanders, Belgium. Transfusion 2015;55:1411\u20137.","DOI":"10.1111\/trf.12947"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_128","doi-asserted-by":"crossref","unstructured":"Lucacevic Krstic J, Dajak S, Bingulac-Popovic J, Dogic V, Mratinovic-Mikulandra J. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population. J Clin Lab Anal 2018;32:e22285.","DOI":"10.1002\/jcla.22285"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_129","doi-asserted-by":"crossref","unstructured":"Safic Stanic H, Kruhonja Galic Z, Dogic V, Bingulac-Popovic J, Jukic I. Serological and molecular characterisation of the most prevalent weak D variants in Croatian population. Transfus Med 2023;33:132\u20136.","DOI":"10.1111\/tme.12944"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_130","unstructured":"Xhetani M, Seferi I, F\u00e9rec C, Zoraqi G, Fichou Y. Distribution of Rhesus blood group antigens and weak D alleles in the population of Albania. Blood Transfus 2014;12:565\u20139."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_131","doi-asserted-by":"crossref","unstructured":"Koutsouri T, Chaikali A, Giannopoulos A, et al. Frequency distribution of RHD alleles among Greek donors with weak D phenotypes demonstrates a distinct pattern in central European countries. Transfus Med 2019;29:468\u201370.","DOI":"10.1111\/tme.12623"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_132","doi-asserted-by":"crossref","unstructured":"Yanasik M, Oguz FS, Besisik SK, et al. Frequency of RHD variants in serologically weak D Turkish blood donors. Transfus Apher Sci 2021;60:103024.","DOI":"10.1016\/j.transci.2020.103024"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_133","doi-asserted-by":"crossref","unstructured":"Oodi A, Daneshvar Z, Goudarzi S, Amirizadeh N. RHD genotyping of serological weak D phenotypes in the Iranian blood donors and patients. Transfus Apher Sci 2020;59:102870.","DOI":"10.1016\/j.transci.2020.102870"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_134","unstructured":"El Housse H, El Wafi M, Ouabdelmoumene Z, et al. Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors. Blood Transfus 2019;17:151\u20136."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_135","doi-asserted-by":"crossref","unstructured":"Ouchari M, Srivastava K, Romdhane H, Yacoub SJ, Flegel WA. Transfusion strategy for weak D type 4.0 based on RHD alleles and RH haplotypes in Thnisia. Transfusion 2018;58:306\u201312.","DOI":"10.1111\/trf.14411"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_136","doi-asserted-by":"crossref","unstructured":"Hussein E, Teruya J. Weak D types in the Egyptian population. Am J Clin Pathol 2013;139:806\u201311.","DOI":"10.1309\/AJCP1T9FGZBHIQET"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_137","doi-asserted-by":"crossref","unstructured":"Abdelrazik AM, Elshafie SM, Ahmed GME, Abdelaziz HM. Combining serology and molecular typing of weak D role in improving D typing strategy in Egypt. Transfusion 2013;53:2940\u20134.","DOI":"10.1111\/trf.12100"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_138","doi-asserted-by":"crossref","unstructured":"Maryam DU, Mukhtar IG, Yusuf AA, Salisu AL High prevalence of serological weak D phenotype and preponderance of weak D type 4.0.1. genetic variant in a Nigerian population: implications for transfusion practice in a resource-limited setting. Hematol Transfus Cell Ther 2022;44:386\u201391.","DOI":"10.1016\/j.htct.2021.01.011"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_139","doi-asserted-by":"crossref","unstructured":"Cruz BR, Chiba AK, Moritz E, Bordin JO. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes. Transfus Med 2012;22:84-9.","DOI":"10.1111\/j.1365-3148.2011.01129.x"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_140","doi-asserted-by":"crossref","unstructured":"Dezan MR, Oliviera VB, Nunes Gomes Q, et al. High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotype. J Clin Lab Anal 2018;32:e22596.","DOI":"10.1002\/jcla.22596"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_141","doi-asserted-by":"crossref","unstructured":"Person RDM, Arnoni CP, Muniz JG, et al. Serologic strategy in detecting RHD altered alleles in Brazilian blood donors. Hematol Transfus Cell Ther 2020;42:365\u201372.","DOI":"10.1016\/j.htct.2019.08.004"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_142","doi-asserted-by":"crossref","unstructured":"Rodrigues ES, Romagnoli AC, Santos FLS, et al. Frequency and characterization of RHD variant alleles in a population of blood donors from southeastern Brazil: comparison with other populations. Transfus Apher Sci 2021;60:103135.","DOI":"10.1016\/j.transci.2021.103135"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_143","doi-asserted-by":"crossref","unstructured":"Trucco Boggione C, Nogues N, Gonzalez-Santesteban C, et al. Characterization of RHD locus polymorphism in D negative and D variant donors from Northwestern Argentina. Transfusion 2019;59:3236-42.","DOI":"10.1111\/trf.15504"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_144","doi-asserted-by":"crossref","unstructured":"Aburto A, Zapata D, Retamales E, et al. Genotype analysis to clarify RhD variants in discrepant samples of Chilean population. Front Immunol 2023;14:1299639.","DOI":"10.3389\/fimmu.2023.1299639"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_145","doi-asserted-by":"crossref","unstructured":"Khetan D, Verma A, Chaudhary RK, Shukla JS. Molecular characterisation of RhD variants in North Indian blood donor population. Transfus Med 2020;30:295-303.","DOI":"10.1111\/tme.12690"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_146","doi-asserted-by":"crossref","unstructured":"Mishra G, Sachan D, Krishna D, Parchure D, Madkaikar M, Kulkami S. Characterising Indian RhD variants by serological and molecular methods. Transfus Med 2020;30:324-6.","DOI":"10.1111\/tme.12689"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_147","doi-asserted-by":"crossref","unstructured":"Zhang X, Li G, Zhou Z, et al. Molecular and computational analysis of 45 samples with a serologic weak D phenotype detected among 132,479 blood donors in northeast China. J Transl Med 2019:17:393.","DOI":"10.1186\/s12967-019-02134-9"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_148","doi-asserted-by":"crossref","unstructured":"Ye L, Li M, Yang Q, Zhu Z. RHD alleles contributing to serologically weak D phenotypes in China: a single-centre study over 10 years. Vox Sang 2022;117:949-57.","DOI":"10.1111\/vox.13275"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_149","unstructured":"Chung YN, Kim TY, Yu H, Bae JC, Cho D. Molecular basis of serological weak D phenotypes and RhD typing discrepancies identified in the Korean population. Blood Transfus 2021; 19:327-34."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_150","doi-asserted-by":"crossref","unstructured":"Isa K, Sasaki K, Ogasawara K, et al. Prevalence of RHD alleles in Japanese individuals with weak D phenotype: identification of 20 new RHD alleles. Vox Sang 2016;111:315-9.","DOI":"10.1111\/vox.12413"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_151","doi-asserted-by":"crossref","unstructured":"McGowan EC, Lopez GH, Knauth CM, et al. Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management. Vox Sang 2017;112:279\u201387.","DOI":"10.1111\/vox.12488"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_152","doi-asserted-by":"crossref","unstructured":"Schoeman EM, Roulis EV, Perry MA, Flower RL, Hyland CA. Comprehensive blood group antigen profile predictions for Western Desert Indigenous Australians from whole exome sequence data. Transfusion 2019;59:768-78.","DOI":"10.1111\/trf.15047"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_153","unstructured":"Jadhao S, Davison C, Roulis E, et al. Genomic characterisation of clinically significant blood group variants in Aboriginal Australians. Blood Transfus 2024;22:464-74."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_154","doi-asserted-by":"crossref","unstructured":"Takasaki K, Friedman DF, Uter S, Vege S, Westhoff CM, Chou ST. Variant RHD alleles and Rh immunization in patients with sickle cell disease. Br J Haematol 2023;201:1220\u20138.","DOI":"10.1111\/bjh.18774"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_155","doi-asserted-by":"crossref","unstructured":"Chang T, Haupfear KM, Yu J, et al. A novel algorithm comprehensively characterizes human RH genes using whole- genome sequencing data. Blood Adv 2020;4:4347-57.","DOI":"10.1182\/bloodadvances.2020002148"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_156","doi-asserted-by":"crossref","unstructured":"Silvy M, Tournamille C, Babinet J, et al. Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype. Haematologica 2014;99:ell6.","DOI":"10.3324\/haematol.2014.104703"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_157","doi-asserted-by":"crossref","unstructured":"Hui YMT, Gurung K, Layton DM, Ibidapo M, Grimsley S, Regan F. Sickle cell disease patients in two London trusts: genotyping including RH variants. Transfus Med 2022;32:210-20.","DOI":"10.1111\/tme.12838"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_158","unstructured":"Desay K, Hill O, Tovey S, Finning K. Red blood cell genotyping to reduce alloimmunization and improve blood selection for haemoglobinopathy patients. Transfus Med 2016;26(Suppl 2):21. Available from https:\/\/www.bbts.org.uk\/downloads\/bbts2016\/presentations\/09.00friqs3bbts2016karendesav.l.pdf. Accessed 26 May 2025."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_159","doi-asserted-by":"crossref","unstructured":"Muniz JG, Arnoni C, Medeiros R, et al. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization. Transfusion 2021;61:2458-67.","DOI":"10.1111\/trf.16544"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_160","unstructured":"Teles B, Santos T, Castilho L. Risk of clinically significant anti-D in sickle cell disease patients with partial D transfused with D-positive red blood cells. Vox Sang 2023;118(Suppl 1):263."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_161","doi-asserted-by":"crossref","unstructured":"Shih AW, Yan MTS, Elahie AL, et al. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk. Transfus Med 2020;30:263-74.","DOI":"10.1111\/tme.12685"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_162","doi-asserted-by":"crossref","unstructured":"Leiva-Torres GA, Cigna M, Constanzo-Yanez J, et al. Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited. Transfusion 2024;64:716-26.","DOI":"10.1111\/trf.17778"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_163","doi-asserted-by":"crossref","unstructured":"Reid ME, Hipsky CH, Hue-Roye K, Hoppe C. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. Blood Cell Mol Dis 2014;52:195-202.","DOI":"10.1016\/j.bcmd.2013.11.003"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_164","doi-asserted-by":"crossref","unstructured":"Chou ST, Evans P, Vege S, et al. RH genotype matching for transfusion support in sickle cell disease. Blood 2018;132: 1198-207.","DOI":"10.1182\/blood-2018-05-851360"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_165","doi-asserted-by":"crossref","unstructured":"Wheeler MM, Lannert KW, Huston H, et al. Genomic characterization of the RH locus detects complex and novel structural variation in multi-ethnic cohorts. Genet Med 2019;21:477-86.","DOI":"10.1038\/s41436-018-0074-9"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_166","doi-asserted-by":"crossref","unstructured":"Israelyan N, Vege S, Friedman DF, et al. RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: a multisite study in the USA. Transfusion 2024;64:526-35.","DOI":"10.1111\/trf.17740"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_167","unstructured":"Macedo MD, Miranda MR, Santos TD, Leal I, Castilho L. Rh antibodies as a result of altered Rh epitopes on transfused red cells: a case series of seven Brazilian patients. Blood Transfus 2021;19:413-9."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_168","doi-asserted-by":"crossref","unstructured":"Kirkegaard J, Rahorst L, Burgos A, et al. Evidence that donors with variant RH genotypes are associated with unexpected Rh antibodies. Transfusion 2023;63:1962-8.","DOI":"10.1111\/trf.17525"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_169","doi-asserted-by":"crossref","unstructured":"Chou ST, Mewha J, Friedman DF, et al. Genotyped RhD+ red cells for D-positive patients with sickle cell disease with conventional RHD and unexpected anti-D. Blood 2024; 144:2045-9.","DOI":"10.1182\/blood.2024025602"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_170","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. Paternal and fetal genotyping in the management of alloimmunization in pregnancy. Obstet Gynecol 2024;144:e47-9.","DOI":"10.1097\/AOG.0000000000005630"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_171","doi-asserted-by":"crossref","unstructured":"Pirelli KJ, Pietz BC, Johnson ST, Pinder HL, Bellissimo DB. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D. Prenat Diagn 2010;30:1207-12","DOI":"10.1002\/pd.2652"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_172","doi-asserted-by":"crossref","unstructured":"Sillence KA, Halawani AJ, Tounsi WA, et al. Rapid RHD zygosity determination using digital PCR. Clin Chem 2017; 63:1388-97.","DOI":"10.1373\/clinchem.2016.268698"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_173","doi-asserted-by":"crossref","unstructured":"Stef M, Fennell K, Apraiz I, et al. RHgenotyping by nonspecific quantitative next-generation sequencing. Transfusion 2020; 60:2691-701.","DOI":"10.1111\/trf.16034"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_174","doi-asserted-by":"crossref","unstructured":"Petch S, Crosby D. Updates in preimplantation genetic testing (PGT). Best Pract Res Clin Obstet Gynaecol 2024;96:102526.","DOI":"10.1016\/j.bpobgyn.2024.102526"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_175","doi-asserted-by":"crossref","unstructured":"Moise KJ, Abels EA. Management of red cell alloimmunization in pregnancy. Obstet Gynecol 2024;144:465-80.","DOI":"10.1097\/AOG.0000000000005709"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_176","doi-asserted-by":"crossref","unstructured":"Seeho SKM, Burton G, Leigh D, Marshall JT, Persson JW, Morris JM. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report. Hum Reprod 2005;20:697-701.","DOI":"10.1093\/humrep\/deh624"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_177","doi-asserted-by":"crossref","unstructured":"Verlinsky Y, Rechitsky S, Ozen S, Masciangelo C, Ayers J, Kuliev A. Preimplantation genetic diagnosis for the Kell genotype. Fertil Steril 2003;80:1047-51.","DOI":"10.1016\/S0015-0282(03)01156-7"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_178","doi-asserted-by":"crossref","unstructured":"Altarescu G, Geva TE, Grisaru-Granovsky S, et al. Preimplantation genetic diagnosis for fetal neonatal alloimmune thrombocytopenia due to antihuman platelet antigen maternal antibodies. Obstet Gynecol 2012;119:338-43.","DOI":"10.1097\/AOG.0b013e318242a11d"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_179","doi-asserted-by":"crossref","unstructured":"Clausen FB. Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D-pregnant women. Immunohematology 2024;40:15-27.","DOI":"10.2478\/immunohematology-2024-004"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_180","doi-asserted-by":"crossref","unstructured":"Mateus-Nino JF, Wynn J, Wiggins-Smith J, et al. Clinical performance of cell-free DNA for fetal RhD detection in RhD- negative pregnant individuals in the US. Obstet Gynecol 2025;145:402-8.","DOI":"10.1097\/AOG.0000000000005850"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_181","doi-asserted-by":"crossref","unstructured":"Thompson MG, Xu W, Moore B, et al. Clinical validation of a prenatal cell-free DNA screening test for fetal RHD in a large U.S. cohort. Obstet Gynecol 2025;145:211-6.","DOI":"10.1097\/AOG.0000000000005794"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_182","doi-asserted-by":"crossref","unstructured":"Moise KJ. The use of free DNA for fetal RHD genotyping in the Rh-negative pregnant patient: the time has come. Am J Obstet Gynecol 2025;232:188-93.","DOI":"10.1016\/j.ajog.2024.08.017"},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_183","unstructured":"American College of Obstetricians and Gynecologists. Rho(D) immune globulin shortages. Practice advisory. March 2024. Available from https:\/\/www.acog.org\/clinical\/dinical-guidance\/practice-advisorv\/articles\/2024\/03\/rhod-immune-globulin-shortages. Accessed 26 May 2025."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_184","unstructured":"Association for the Advancement of Blood & Biotherapies. Association Bulletin #24-02. Use of Rh immune globulin and considerations in the setting of supply shortages and limited availability. 15 July 2024. Available from https:\/\/www.aabb.org\/news-resources\/resources\/association-bulletins. Accessed 26 May 2025."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_185","unstructured":"Levine P, Rosenfield RE, White J. The first example of the Rh phenotype rGrG. Am J Hum Genet 1961;13:299-305."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_186","unstructured":"Issitt PD. Serology and genetics of the Rhesus blood group system. Cincinnati, OH: Montgomery Scientific, 1979:1."},{"key":"2026071214321550176_j_immunohematology-2025-007_ref_187","unstructured":"Pierce SR, Reid ME. Bloody brilliant: a history of blood groups and blood groupers. Bethesda, MD: AABB Press, 2016:253."}],"container-title":["Immunohematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/immunohematology-2025-007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:25:16Z","timestamp":1783905916000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/immunohematology-2025-007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":187,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,7,8]]},"published-print":{"date-parts":[[2025,6,1]]}},"alternative-id":["10.2478\/immunohematology-2025-007"],"URL":"https:\/\/doi.org\/10.2478\/immunohematology-2025-007","relation":{},"ISSN":["1930-3955"],"issn-type":[{"value":"1930-3955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}